| Species : |
Human |
| Source : |
HEK293 |
| Tag : |
His |
| Protein Length : |
27-191 aa |
| Form : |
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
| Bio-activity : |
1. Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human VEGF165 at 1 μg/mL (100 μL/well) can bind Recombinant Human VEGFR2 with a linear range of 8-20 ng/mL. 2. Measured by its binding ability in a functional ELISA. Immobilized Human VEGF165 at 2 μg/mL (100 μL/well) can bind Human KDR with a linear range of 0.2-11.6 ng/mL. 3. Recombinant Human VEGF165 stimulates cell proliferation of the human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 0.19-0.78 ng/mL, corresponding to a specific activity of 1.28 × 10^6~5.26× 10^6 units/mg. |
| Molecular Mass : |
20.01 kDa |
| Endotoxin : |
< 0.1 EU/μg of the protein by LAL method. |
| Purity : |
≥ 95 % as determined by SDS-PAGE; ≥ 95 % as determined by HPLC. |
| Storage : |
Store at -20°C.Store the lyophilized protein at -20°C to -80°C up to 1 year from the date of receipt.After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week. |
| Reconstitution : |
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |